Bone and metabolic health in trans and gender diverse individuals receiving testosterone or oestrogen as cross-sex hormone therapy

Cyproterone acetate or spironolactone in lowering testosterone concentrations for transgender individuals receiving oestradiol therapy

Lachlan Angus, Shalem Leemaqz, Olivia Ooi, Pauline Cundill, Nicholas Silberstein, Peter Locke, Jeffrey D Zajac, Ada S Cheung

2019-07-01

Background: Oestradiol with or without an anti-androgen (cyproterone acetate or spironolactone) is commonly prescribed in transfem..

Sociodemographic and Clinical Characteristics of Transgender Adults in Australia.

Ada S Cheung, Olivia Ooi, Shalem Leemaqz, Pauline Cundill, Nicholas Silberstein, Ingrid Bretherton, Emily Thrower, Peter Locke, Mathis Grossmann, Jeffrey D Zajac

2018-01-01

Background: Over the last 10 years, increases in demand for transgender health care has occurred worldwide. There are few data on ..